Skip to main content
. 2019 Apr 29;4(2):e001343. doi: 10.1136/bmjgh-2018-001343

Table 3.

Loss-to-follow-up and follow-up rates of cohort analysis patients

NCD cohort LTFU* Facility (MLP) Community (CHW) Combined
Follow-up visits Days between last two visits Follow-up visits Days between last two visits Monthly touch-points per patient
(%) Median
(Q1,Q3)
Median
(Q1,Q3)
Median
(Q1,Q3)
Median
(Q1,Q3)
Median
(Q1,Q3)
Diabetes 16 6 (44, 8) 67 (38, 126) 10 (44, 13) 29 (2121, 41) 0.9 (0.5, 1.2)
Hypertension 19 6 (44, 9) 62 (36, 111) 10 (55, 13) 30 (2525, 42) 0.9 (0.6, 1.2)
COPD 22 7 (44, 9) 56 (34, 98) 11 (66, 14) 30 (2626, 39) 0.9 (0.7, 1.3)

*A patient was defined as LTFU if they never had a follow-up visit at the facility. These patients were excluded from the analysis cohort.

CHW, community health worker; COPD, chronic obstructive pulmonary disease; LTFU, lost to follow-up; MLP, mid-level practitioner; NCD, non-communicable disease.